- Active not recruitingPHASE2, PHASE3
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
This study looks at a new drug, fianlimab, combined with cemiplimab, for advanced lung cancer. It aims to see if this combination works better than cemiplimab alone, studying side effects and how treatments affect quality of life.
For: Advanced Non-Small Cell Lung CancerUnited States · Australia · Canada - Active not recruitingPHASE3
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
This study looks at new drug combinations (fianlimab with cemiplimab) versus a standard drug (pembrolizumab) to see if they can stop melanoma from coming back after surgery. It's for people at high risk of their melanoma returning.
For: MelanomaUnited States · Argentina · Australia - Active not recruitingPHASE3
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
This study is comparing two drug combinations for advanced melanoma skin cancer: fianlimab plus cemiplimab, and pembrolizumab. It aims to see which is more effective, what side effects occur, and how they affect adults and teenagers.
For: MelanomaUnited States · Argentina · Australia - Active not recruitingPHASE2
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
This study is looking at a new drug combination for lung cancer that can be removed by surgery. It aims to see if adding Fianlimab to standard treatment (Cemiplimab and chemotherapy) works better and is safe for adults with certain types of non-small cell lung cancer.
For: Resectable Non-small Cell Lung CancerUnited States · Australia · Chile